Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

Antivenin (Crotalidae) Polyvalent

Antivenin (Crotalidae) Polyvalent is an FDA-licensed reference biologic from Wyeth Pharmaceuticals LLC.

351(a) biologicBLA 101098 Wyeth Pharmaceuticals LLC
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
1954

Reference product

Originator biologic
Ask AI
351(a)BLA 101098

Not listed Antivenin (Crotalidae) Polyvalent

Wyeth Pharmaceuticals LLC

View full reference-product record
Approved
Marketing
Disc
Center
CBER
Patents
None listed

Exclusivity & patent cliffs

Protection horizon
Ask AI
  1. Reference approval

    Approval date of the reference Antivenin (Crotalidae) Polyvalent product.

    73 yr 10 mo ago

Antivenin (Crotalidae) Polyvalent: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Antivenin (Crotalidae) Polyvalent.

Related FDA reference tools

Assyro Intelligence

Ask anything about Antivenin (Crotalidae) Polyvalent

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo